Page last updated: 2024-08-23

imidazole-2-hydroxybenzoate and Chronic Disease

imidazole-2-hydroxybenzoate has been researched along with Chronic Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acuto, GC; Bianchini, C; de Santis, F; Morin, D; Tillement, JP; Zini, R1
Gatto, A; Moro, U; Punzo, G; Sagliaschi, G; Torrini, G1

Other Studies

2 other study(ies) available for imidazole-2-hydroxybenzoate and Chronic Disease

ArticleYear
Blood binding of selezen (imidazole salicylate) in man.
    International journal of clinical pharmacology, therapy, and toxicology, 1991, Volume: 29, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Chronic Disease; Dialysis; Erythrocytes; Humans; Imidazoles; Kidney Failure, Chronic; Liver Diseases; Salicylates; Salicylic Acid

1991
[Controlled clinical study on the use of imidazole-2-hydroxybenzoate in prostatitis].
    Recenti progressi in medicina, 1987, Volume: 78, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Humans; Imidazoles; Male; Pipemidic Acid; Prostatitis; Random Allocation; Salicylates; Suppositories

1987